Hazra, M. (2019) “A rational pharmacotherapeutic study of comparative safety among topical anti-acne 1% nadifloxacin monotherapy, 0.1% adapalene monotherapy, 0.025% tretinoin monotherapy, 1% nadifloxacin and 0.1% adapalene combination therapy and 1% nadifloxacin and 0.025% tretinoin combination therapy, in mild to moderate acne vulgaris, in tertiary care hospitals”, International Journal of Basic & Clinical Pharmacology, 8(9), pp. 1959–1965. doi: 10.18203/2319-2003.ijbcp20193662.